The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer

American Surgeon

Volumn 71, Issue 9, 2005, Pages 731-734

  Podnos, Yale D ^a   Smith, David ^a   Wagman, Lawrence D ^a   Ellenhorn, Joshua D I ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CANCER REGISTRY; HUMAN; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; STATISTICS; SURVIVAL; THYROID TUMOR; UNITED STATES;

ADENOCARCINOMA, FOLLICULAR; ADENOCARCINOMA, PAPILLARY; ADULT; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; SEER PROGRAM; SURVIVAL ANALYSIS; THYROID NEOPLASMS; UNITED STATES;

EID: 33644940523     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. American Cancer Society. Available at www.cancer.org/downloads/stt/ CAFF2005F4PWsecured.pdf. Accessed 7/18/2005.
2. Cady B, Sedgwick C, Meissner WA, et al. Risk factor analysis in differentiated thyroid cancer. Cancer 1979;43:810-820 (Pubitemid 9163606)
3. Hay ID, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088-1092 (Pubitemid 18010757)
4. Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050-1058
5. American Joint Committee on Cancer. Available at www.cancerstaging.org/ education/tnmschema/thyroid.ppt#3. AJCC Cancer Staging Manual, sixth edition (2002).
6. Hughes CJ, Shaha AR, Shah JP, Loree TR. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 1996;18:127-132 (Pubitemid 26075352)
7. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clini Endocrin Metab 1990;71:414-424 (Pubitemid 20261828)
8. Cunningham WJ, McKinney SE, Carruthers JS, et al. Survival discriminants for differentiated thyroid cancer. Am J Surg 1990;160:344-347
9. Shaha AR, Shah JP, Loree TR. Risk group stratification and prognostic factors in papillary carcinoma of the thyroid. Ann Surg Onc 1996;3:534-538 (Pubitemid 126729002)
10. Cady B, Sedgwick CE, Meissner WA, et al. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 1976;184:541-552
11. McHenry CR, Rosen IB, Walfish PG. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 1991;162:353-356
12. Coburn MC, Wanebo HJ. Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg 1992;164:671-676
13. Shah JP, Loree TR, Dharker D, et al. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992;164:658-661
14. Kim S, Wei JP, Braveman JM, Brams DM. Predicting outcome and directing therapy for papillary thyroid carcinoma. Arch Surg 2004;139:390-394 (Pubitemid 38451581)
15. Attie JN, Khafif RA, Steckler RM. Elective neck dissection in papillary carcinoma of the thyroid. Am J Surg 1971;122:464-471
16. Sanders LE, Cady B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 1998;133:419-425 (Pubitemid 28193527)